Health-care companies were more or less flat as traders rotated back into a sector that took the brunt of last week's selloff. Shares of vaccine makers such as Moderna and Novavax rose, following a ...

B.Riley Financial analyst Mayank Mamtani has maintained their bullish stance on NVAX stock, giving a Buy rating on November 13.Don't Miss our ...

(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...

If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s important to ...

Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...

Health-care companies fell sharply as the selection of Robert F. Kennedy Jr. as Donald Trump's nominee to head the Department of Health and Human Services weighed on vaccine makers. Shares of Pfizer, ...

Shares of Novavax Inc. NVAX rose 1.39% to $7.32 Friday, on what proved to be an all-around rough trading session for the ...

JP Morgan Chase analysts say they’re ‘not surprised’ sector has come ‘under pressure’ since Kennedy’s nomination ...

Remember when everyone was excited the stock market spiked after Trump’s election win? Well, turns out it was very ...

Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX ...

The stocks for three pharmaceutical companies heavily involved in the production of vaccines fell drastically by market close ...

Wall Street is absorbing a jump in retail sales and Jerome Powell's hawkish comments as Trump-fueled optimism starts to wear ...